Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LXGTF starting green!
LXGTF Press Release from October 23, 2017: LXGTF receives delivery of first HeartSentry units from the manufacturer.:
http://www.otcmarkets.com/stock/LXGTF/news/Lexington-Biosciences-Receives-HeartSentry-Trial-Units?id=173009&b=y
GOOD ARTICLE RECENTLY RELEASED
https://insiderfinancial.com/lexington-bioscien-otcmktslxgtf-venturing-into-fortune-500-territory
The FACTS ARE: Undiagnosed Cardiovascular Disease Is a Killer
• 1 in 3 deaths annually are caused by heart disease
and stroke.
• 1.5 million people suffer heart attacks annually in
the U.S.
• Nearly 1/3 of the deaths could be prevented
through proactive changes in lifestyle habits.
• Often the FIRST SYMPTOM of coronary artery
disease is a heart attack.
The FACTS ARE: Undiagnosed Cardiovascular Disease Is a Killer
• 1 in 3 deaths annually are caused by heart disease
and stroke.
• 1.5 million people suffer heart attacks annually in
the U.S.
• Nearly 1/3 of the deaths could be prevented
through proactive changes in lifestyle habits.
• Often the FIRST SYMPTOM of coronary artery
disease is a heart attack.
WHY LXGTF is better? Knowing the core health of the cardiovascular system is critical to preventing future heart attacks and strokes
• Monitoring cardiovascular health changes over time is key to prevention via lifestyle modification, physician care and ongoing monitoring.
• Traditional measures of blood pressure and cholesterol measurements are only partial indicators of cardiovascular health.
WOW, good to see green start!
THE FUTURE IS LIKE THAT "These updates and developments from an industry giant such as Overstock.com are just further evidence that our model, our direction, and our ideas are not only viable, but that we are ahead of the curve and are poised to earn a tremendous market share of the cryptocurrency and online crypto retail business as more and more companies embrace cryptocurrency", stated Eric Sills, CEO of Adama Technologies.
GOOD WORK! "We are envisioning a product where a customer can log into their app, trade and exchange tokens, shop for their favorite products, move tokens between wallets and transfer money to their connected card, bank or other online wallet accounts. Our team of designers and developers have really caught the vision of what we are trying to build and what we will accomplish in blending and marrying the cryptocurrency and online retail sectors.
Good morning everybody :)
check the amazing LXGTF Management Team: https://lexingtonbiosciences.com/company/management/
LXGTF Article by Jonathan Maltz, "What is Endothelial Function..." :
https://lexingtonbiosciences.com/news/endothelial-function-important-health/
WATCH LXGTF video: https://vimeo.com/183611304
UNDERSTAND "Breakthrough technology". In LXGTF HeartSentry you have a simple, affordable, portable device that requires no expert training to use and yet by measuring endothelial function it can knock the wind out of the diseases that cause 25% of ALL deaths in the modern world (heart disease and stroke)Its only competition area devices that cost up to six figures, can fill a small room and require medical training to operate.
NEW TO LXGTF? NEED SOME READING MATERIAL??
START DD HERE:
https://lexingtonbiosciences.com/wp-content/uploads/2017/10/Lexington-Website-Presentation.pdf
time for breakthrough today IMO
Good morning everybody!
LXGTF is potential 50 Billion Dollar Industry!
Read More here:
https://t.co/4nL5f2LtnQ
About Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF)
Lexington Biosciences is a medical device company developing the HeartSentry, a new non-invasive diagnostic device to measure and monitor cardiovascular health by assessing the function of a person's vascular endothelium - the vital innermost lining of a person's cardiovascular system. Currently, the standard of care is measurement using expensive external ultrasound by a highly trained technician. The HeartSentry core technology was developed at the University of California Berkeley over a fifteen-year R&D period involving many research studies and product iterations resulting in portfolio of multiple pending and issued patents licensed to the company. By taking delivery of the clinical trial ready HeartSentry units the company will commence studies as soon as possible. Our aim is to make HeartSentry accurate, quick, and cost effective so it can become the standard of care for cardiologists, general practitioners, and ultimately patients for first line evaluation of a person's cardiovascular health. Lexington is engaged with the US FDA and other regulatory agencies on the required product approvals for the HeartSentry. For more information about the company please visit:
https://lexingtonbiosciences.com/
Eric Willis
CEO & Director
THE POINT! The First Sign of Cardiovascular Disease is Often an Unannounced Heart Attack!
• Current first line cardiovascular health
diagnostics are insensitive at measuring
heart disease development and
progression
• Specialized cardiovascular diagnostics
are highly invasive and expensive and
generally catch cardiovascular disease
AFTER it’s developed
...we need a simple way to proactively measure and monitor
cardiovascular system health BEFORE the development of heart disease
I think something can come in the next period if they don't have other reasons not to issue it
Very conmfortable
START DD HERE IF YOU ARE NEW ON BOARD:
https://lexingtonbiosciences.com/wp-content/uploads/2017/10/Lexington-Website-Presentation.pdf
You explained it well SuperPacMan, thank you !
This is an amazing data
What a point: Blood pressure monitor market forecast to exceed $2.6 billion by 2020
exactly, alarm, great point in changing of lifestyle
SUMMARY LXGTF : Lexington BioSciences (CSE: LNB) (OTCQB: LXGTF) is developing the HeartSentry, a new non-invasive diagnostic tool for accurately measuring and monitoring cardiovascular health.
• The HeartSentry measures the function of the endothelium – the critical inner lining of a person’s cardiovascular system.
• The core research and IP portfolio has been exclusively licensed to the company.
• Lexington is in final stages of releasing the product into clinical studies for FDA approval.
• The cardiovascular diagnostic market is growing fast and evolving into
personalized medicine.
• The goal is to make HeartSentry the standard of care for cardiologists, general practitioners, and ultimately patients first line evaluation of cardiovascular health.
• We seek the participation of dedicated stakeholders and committed
partners who share our vision of the future of cardiovascular personalized medicine.
LXGTF simplify and save lifes! Current Standards are Complicated and Expensive
• Gold standard - ULTRASOUND
• Measurement directly views arterial diameter
changes
• Only at specialized diagnostic centers
• Requires trained ultrasonographer
• Expensive capital equipment needed
• Alternative method - ENDOPAT
• Measurement uses a fingertip blood oxygen
sensor and laptop computer.
• Only at specialized diagnostic centers
• Requires trained technician
Currently only used in specialized research centers by highly trained staff
let's break the line in green
Adama plans to introduce a powerful solution into the market and will offer Identity Theft Protection Programs as an employee benefit to corporate clients and has already secured three corporate contracts with more than 100 employees already enrolled in the benefit program. Mark Brown, Director and Lead Executive of SafeGuard, has more than 25 years of experience in data security and management. His teams are seeing tremendous demand for Identity Theft Protection Programs especially for corporate clients. Mr. Brown commented about the strategy and opportunity surrounding SafeGuard, "Identity theft is not confined to just individuals. Criminals are getting very good at stealing business identities. The rapid rise in business identity theft now puts every business and business owner at serious risk. The Wall Street Journal has reported that 60% of businesses that suffer business identity fraud close their doors within 1 year. To combat this serious issue and protect the assets that small business owners have worked their lifetime to accumulate, SafeGuard offers affordable, effective solutions specifically designed for small to midsized businesses, to business owners."
this is great
The Power Hour is starting soon, we haven't seen any changes in the last few but it will good to go in green
GREAT LXGTF video: https://vimeo.com/183611304
NEW HERE? Start your dd from LXGTF website: https://lexingtonbiosciences.com/
some good pont here
We need it
LXGTF engages Diablo research for next step in FDA clearance..
https://finance.yahoo.com/news/lexington-biosciences-engages-clinical-research-140000876.html
LXGTF engages Diablo research for next step in FDA clearance..
https://finance.yahoo.com/news/lexington-biosciences-engages-clinical-research-140000876.html